Top compounds associated with response to RABL2A


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.087 0.004
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.1 0.004
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.082 0.005
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.005
mRNA SL 0101-1 GDSC1000 pan-cancer AAC 0.099 0.005
mRNA PHA-793887 GDSC1000 pan-cancer AAC 0.078 0.006
mRNA YM201636 GDSC1000 pan-cancer AAC 0.085 0.006
mRNA TAE684 GDSC1000 pan-cancer AAC -0.14 0.006
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.1 0.007
Download CSV